These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30729893)

  • 61. Home blood pressure monitoring: international recognition.
    Krakoff LR
    Hypertension; 2014 Apr; 63(4):670-1. PubMed ID: 24420539
    [No Abstract]   [Full Text] [Related]  

  • 62. New vascular biomarkers related to ABPM phenotypes in untreated patients.
    Ruilope LM; Ruiz-Hurtado G
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):53-54. PubMed ID: 30525277
    [No Abstract]   [Full Text] [Related]  

  • 63. Subclinical arterial and cardiac damage in white-coat and masked hypertension.
    Wojciechowska W; Stolarz-Skrzypek K; Olszanecka A; Klima Ł; Gąsowski J; Grodzicki T; Kawecka-Jaszcz K; Czarnecka D
    Blood Press; 2016 Aug; 25(4):249-56. PubMed ID: 26953075
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Home and ambulatory blood pressure in resistant hypertension.
    Grassi G; Facchetti R; Seravalle G; Cuspidi C; Mancia G
    EuroIntervention; 2013 May; 9 Suppl R():R35-41. PubMed ID: 23732153
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Current approach to masked hypertension: From diagnosis to clinical management.
    Dolan E; James K
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1272-1278. PubMed ID: 24283851
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The complexity of masked hypertension: diagnostic and management challenges.
    Franklin SS; Wong ND
    Curr Hypertens Rep; 2014 Sep; 16(9):474. PubMed ID: 25097111
    [TBL] [Abstract][Full Text] [Related]  

  • 67. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.
    Parati G; Stergiou G; O'Brien E; Asmar R; Beilin L; Bilo G; Clement D; de la Sierra A; de Leeuw P; Dolan E; Fagard R; Graves J; Head GA; Imai Y; Kario K; Lurbe E; Mallion JM; Mancia G; Mengden T; Myers M; Ogedegbe G; Ohkubo T; Omboni S; Palatini P; Redon J; Ruilope LM; Shennan A; Staessen JA; vanMontfrans G; Verdecchia P; Waeber B; Wang J; Zanchetti A; Zhang Y;
    J Hypertens; 2014 Jul; 32(7):1359-66. PubMed ID: 24886823
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Understanding Blood Pressure Variation and Variability: Biological Importance and Clinical Significance.
    James GD
    Adv Exp Med Biol; 2017; 956():3-19. PubMed ID: 27722957
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of miscuffing during home blood pressure measurement on the prevalence of masked hypertension.
    Mourad JJ; Lopez-Sublet M; Aoun-Bahous S; Villeneuve F; Jaboureck O; Dourmap-Collas C; Denolle T; Fourcade J; Baguet JP
    Am J Hypertens; 2013 Oct; 26(10):1205-9. PubMed ID: 23727841
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ABPM Induced Alarm Reaction: A Possible Cause of Overestimation of Daytime Blood Pressure Values Reduced By Treatment with Beta-Blockers.
    Salvo F; Lonati C; Albano M; Fogliacco P; Errani AR; Vallo C; Berardi M; Meinero V; Muzzulini CL; Morganti A
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):255-8. PubMed ID: 27272934
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A critical appraisal of the guidelines from France, the UK, Europe and the USA for the management of hypertension in adults.
    Stephan D; Gaertner S; Cordeanu EM
    Arch Cardiovasc Dis; 2015; 108(8-9):453-9. PubMed ID: 26113481
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study.
    Hänninen MR; Niiranen TJ; Puukka PJ; Johansson J; Jula AM
    J Hypertens; 2012 Apr; 30(4):705-12. PubMed ID: 22278146
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Current status of white coat hypertension: where are we?
    Nuredini G; Saunders A; Rajkumar C; Okorie M
    Ther Adv Cardiovasc Dis; 2020; 14():1753944720931637. PubMed ID: 32580646
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predicting out-of-office blood pressure level using repeated measurements in the clinic: an observational cohort study.
    Sheppard JP; Holder R; Nichols L; Bray E; Hobbs FD; Mant J; Little P; Williams B; Greenfield S; McManus RJ
    J Hypertens; 2014 Nov; 32(11):2171-8; discussion 2178. PubMed ID: 25144295
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Role of Out-of-Clinic Blood Pressure Measurements in Preventing Hypertension.
    Chen Y; Zhang DY; Li Y; Wang JG
    Curr Hypertens Rep; 2018 Jul; 20(10):85. PubMed ID: 30062568
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Management of arterial hypertension].
    Wermelt JA; Schunkert H
    Herz; 2017 Aug; 42(5):515-526. PubMed ID: 28555286
    [TBL] [Abstract][Full Text] [Related]  

  • 77. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
    Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
    Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
    [TBL] [Abstract][Full Text] [Related]  

  • 78. How should we manage a patient with masked hypertension?
    Palatini P
    High Blood Press Cardiovasc Prev; 2015 Mar; 22(1):11-6. PubMed ID: 24500867
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Resistant hypertension: a practical clinical approach.
    Muxfeldt ES; de Souza F; Salles GF
    J Hum Hypertens; 2013 Nov; 27(11):657-62. PubMed ID: 23636008
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
    Bookstaver DA; Hatzigeorgiou C
    Ann Pharmacother; 2011 Jul; 45(7-8):910-5. PubMed ID: 21750311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.